IMPEDIMED LIMITED — Director's Dealing 2026

Jun 3, 2026

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: ImpediMed Limited
ABN: 089 705 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Ms Janelle Delaney
Date of last notice	16 January 2026

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.	Mr Todd Delaney and Mrs Janelle Delaney as trustee for the Delaney Family Superannuation Fund.
Ms Delaney is a trustee and a beneficiary of the superannuation fund.
Date of change	02 June 2026
No. of securities held prior to change	Direct
1,982,044 Ordinary shares
Indirect
2,921,387 Ordinary shares
Class	Ordinary shares
Number acquired	Direct
221,739 Ordinary shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1

---

Appendix 3Y

Change of Director's Interest Notice

Number disposed	Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation	$0.0161 per share
No. of securities held after change	Direct
2,203,783 Ordinary shares

Indirect
2,921,387 Ordinary shares |
| Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Issue of shares in lieu of 15% of non-executive director fees for quarter ended 31 March 2026. |

Part 2 – Change of director’s interests in contracts

Not applicable.

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 – ${}^{+}$ Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

Date of Notice: 03 June 2026

• See chapter 19 for defined terms.

Appendix 3Y Page 2